The KU Leuven is a Catholic research university in the city of Leuven, Belgium. It conducts teaching, research, and services in computer science, engineering, natural sciences, theology, humanities, medicine, law, canon law, business, and social sciences.

During the past decade, KU Leuven conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "KU Leuven" #1 sponsor was "KU Leuven" with 56 trials, followed by "Universitaire Ziekenhuizen KU Leuven" with 28 trials sponsored, "European Pathway Association" with 3 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials sponsored and "Assistance Publique - Hôpitaux de Paris" with 2 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "KU Leuven" #1 collaborator was "KU Leuven" with 25 trials as a collaborator, "Universitaire Ziekenhuizen KU Leuven" with 14 trials as a collaborator, "Research Foundation Flanders" with 9 trials as a collaborator, "University Ghent" with 4 trials as a collaborator and "European Union" with 3 trials as a collaborator. Other collaborators include 136 different institutions and companies that were collaborators in the rest 130 trials.

According to Clinical.Site data, the most researched conditions in "KU Leuven" are "Low Back Pain" (6 trials), "Chronic Obstructive Pulmonary Disease" (5 trials), "Healthy" (5 trials), "Functional Dyspepsia" (3 trials) and "Parkinson Disease" (3 trials). Many other conditions were trialed in "KU Leuven" in a lesser frequency.

Most popular intervention types in "KU Leuven" are "Other" (35 trials), "Drug" (26 trials), "Behavioral" (19 trials), "Device" (18 trials) and "Dietary Supplement" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Oxytocin" (6 trials), "Boston Scientific: Study tool computer" (2 trials), "HepaStem" (2 trials) and "Ketone ester" (2 trials). Other intervention names were less common.

The vast majority of trials in "KU Leuven" are 120 trials for "All" genders, 7 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are 28 active trials in "KU Leuven". 1 are not yet recruiting, 16 are recruiting, 7 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 81 completed trials in KU Leuven, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in KU Leuven, 5 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 62 trials that are defined as “Not Applicable".

KU Leuven has several departments that took part in Clinical trials: "Faculty of Kinesiology and Rehabilitation Sciences" - 11 trials, "Department of Rehabilitation Sciences KU Leuven" - 6 trials, "Exercise Physiology Research Group" - 3 trials, "Department of Movement Sciences" - 3 trials, "Leuven Cancer Institute" - 2 trials, "BIOMAT, Department of Oral Health Sciences" - 2 trials, "Radiology Department" - 2 trials, "Department of Nephrology and Renal Transplantation, University Hospitals Leuven" - 2 trials, "Dept Internal Medicine Gastrointestinal Oncology Unit" - 2 trials, "KU Leuven, Experimental ORL, Dept Neurosciences" - 2 trials